The U.S. Food and Drug Administration placed a clinical hold on a study of BiomX's cystic fibrosis treatment in order to review data on the third-party nebulizer used to deliver the drug. Patient ...

The U.S. Food and Drug Administration has turned away PTC Therapeutics' proposed vatiquinone treatment for the rare, inherited neurodegenerative disorder Friedreich's ataxia over concerns about the ...